CD8A and infection: Consistent with early observations in clinical trials (22), the mouse model using murine CMV (mCMV) for experimental infection (23) has identified timely reconstitution, priming, and clonal expansion of high-avidity CMV-specific CD8 T cells as being essential for preventing CMV disease in HCT recipients [for recent reviews, see (24, 25)].